Cinclus Pharma participates in Aktiespararnas event Småbolagsdagarna on June 12.

Cinclus News Aktiespararna Eng Christer

On June 12, Christer Ahlberg, CEO of Cinclus Pharma, will present the company and the development of the drug candidate linaprazan glurate at Aktiespararnas event Småbolagsdagarna. The presentation will take place at 10:55.

Read more (in Swedish): Småbolagsdagarna